These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 9692773

  • 1. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [Abstract] [Full Text] [Related]

  • 2. Receptor density as a factor governing the efficacy of the dopamine D4 receptor ligands, L-745,870 and U-101958 at human recombinant D4.4 receptors expressed in CHO cells.
    Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Langenegger D, Sommer B, Hoyer D, Tricklebank M, Schoeffter P.
    Br J Pharmacol; 1999 Oct; 128(3):613-20. PubMed ID: 10516640
    [Abstract] [Full Text] [Related]

  • 3. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 4. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S, Patel S, Marwood R, Emms F, Marston D, Leeson PD, Curtis NR, Kulagowski JJ, Freedman SB.
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [Abstract] [Full Text] [Related]

  • 5. Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.
    Hall DA, Strange PG.
    Br J Pharmacol; 1997 Jun; 121(4):731-6. PubMed ID: 9208141
    [Abstract] [Full Text] [Related]

  • 6. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G, Knowles MR, Ward-Booth SM, Sinclair HA, Patel S, Marwood R, Emms F, Patel S, Smith A, Seabrook GR.
    J Recept Signal Transduct Res; 1995 Jun; 15(1-4):267-81. PubMed ID: 8903944
    [Abstract] [Full Text] [Related]

  • 7. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA, Chu A, Sibley DR.
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [Abstract] [Full Text] [Related]

  • 8. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
    Gazi L, Schoeffter P, Nunn C, Croskery K, Hoyer D, Feuerbach D.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):555-64. PubMed ID: 10832611
    [Abstract] [Full Text] [Related]

  • 9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 10. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ, Newman-Tancredi A, Brocco M, Gobert A, Lejeune F, Audinot V, Rivet JM, Schreiber R, Dekeyne A, Spedding M, Nicolas JP, Peglion JL.
    J Pharmacol Exp Ther; 1998 Oct 15; 287(1):167-86. PubMed ID: 9765336
    [Abstract] [Full Text] [Related]

  • 11. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct 15; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 12. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
    Patel S, Freedman S, Chapman KL, Emms F, Fletcher AE, Knowles M, Marwood R, Mcallister G, Myers J, Curtis N, Kulagowski JJ, Leeson PD, Ridgill M, Graham M, Matheson S, Rathbone D, Watt AP, Bristow LJ, Rupniak NM, Baskin E, Lynch JJ, Ragan CI.
    J Pharmacol Exp Ther; 1997 Nov 15; 283(2):636-47. PubMed ID: 9353380
    [Abstract] [Full Text] [Related]

  • 13. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 14. Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
    Yamaguchi I, Walk SF, Jose PA, Felder RA.
    Mol Pharmacol; 1996 Feb 27; 49(2):373-8. PubMed ID: 8632772
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):348-56. PubMed ID: 17070976
    [Abstract] [Full Text] [Related]

  • 16. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB, Terranova MA, Chang R, Uchic ME, Matulenko MA, Surber BW, Stewart AO, Brioni JD.
    Eur J Pharmacol; 2004 Aug 23; 497(2):147-54. PubMed ID: 15306199
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of a human dopamine D4 receptor expressed in HEK293 cells.
    Lawson CF, Mortimore RA, Schlachter SK, Smith MW.
    Methods Find Exp Clin Pharmacol; 1994 Jun 23; 16(5):303-7. PubMed ID: 7934308
    [Abstract] [Full Text] [Related]

  • 18. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M, Zhang L, Rotondo A, Sun H, Morales M.
    Synapse; 2003 Dec 15; 50(4):303-13. PubMed ID: 14556235
    [Abstract] [Full Text] [Related]

  • 19. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M, Cowart MD, Hsieh GC, Miller L, Uchic ME, Chang R, Terranova MA, Donnelly-Roberts DL, Namovic MT, Miller TR, Wetter JM, Marsh K, Stewart AO, Brioni JD, Moreland RB.
    Neuropharmacology; 2005 Jul 15; 49(1):112-21. PubMed ID: 15992586
    [Abstract] [Full Text] [Related]

  • 20. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD.
    J Pharmacol Exp Ther; 1997 Dec 15; 283(3):1256-63. PubMed ID: 9400001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.